Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Cell Stress & Chaperones|July 18, 2014
C-terminal amino acids are essential for human heat shock protein 70 dimerizationGuillaume Marcion, Renaud Seigneuric, Evelyne Chavanne, et al.Molecular Oncology|May 7, 2022
Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkersMohammed I Y Elmallah, Pablo Ortega-Deballon, Laure Hermite, et al.Journal of Extracellular Vesicles|February 1, 2020
Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patientsMarine Cordonnier, Charlée Nardin, Gaëtan Chanteloup, et al.Journal of Extracellular Biology|June 24, 2025
Monitoring Pseudoprogression Using Circulating Small Extracellular Vesicles Expressing PD-L1 in a Melanoma Patient Treated With Immune Checkpoint InhibitorsCharlée Nardin, Valentin Vautrot, Isen Naiken, et al.Acta Dermato-Venereologica|August 27, 2019
Increased Levels of Interleukin-17A Exosomes in PsoriasisClaire Jacquin-Porretaz, Marine Cordonnier, Charlée Nardin, et al.Cell Communication and Signaling : CCS|June 16, 2026
Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cellsSergen Arslan, Alexandre Barbaud, Jason Bernauer, et al.European Journal of Medicinal Chemistry|April 17, 2010
Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogsFrédéric Mazué, Didier Colin, Jessica Gobbo, et al.JMIR Research Protocols|September 9, 2025
Small Extracellular Vesicles as Biomarkers in Sarcoma Follow-Up: Protocol for a Prospective, Multicentric Pilot StudyValentin Vautrot, Alice Hervieu, Aurélie Bertaut, et al.Oncotarget|April 27, 2017
Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cellsDominique Thuringer, Gaetan Chanteloup, Jonathan Boucher, et al.Clinical Colorectal Cancer|November 28, 2021
Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II StudyAurelie Bertaut, Yann Touchefeu, Julie Blanc, et al.Pageof 4